Drugs & Targets FDA approves FoundationOne CDx as companion diagnostic for BRAF inhibitor therapeutics in melanoma December 10, 2021Vol.47 No.45
Drugs & Targets FDA approves Oncomine Dx Target Test as CDx for Rybrevant December 10, 2021Vol.47 No.45
Drugs & Targets FDA accepts sBLA for BMS’ Reblozyl for priority review in adults with non-transfusion dependent beta thalassemia December 10, 2021Vol.47 No.45
Drugs & Targets M2GEN, Microsoft to collaborate on bioinformatics solutions for oncology December 10, 2021Vol.47 No.45
Regulatory News FDA cancels second ODAC in a row as two accelerated approval drugs are yanked by sponsors (and one still dangles) December 03, 2021Vol.47 No.44By Alice Tracey
Auction lot No. 3: E. Donnall Thomas’s Nobel Prize medal (min. bid: $250,000) December 03, 2021Vol.47 No.44By Alice Tracey
In Brief Richard Fisher steps down from leadership roles at Fox Chase Cancer Center December 03, 2021Vol.47 No.44
In Brief Scott Lippman named vice chancellor, transitioning from UCSD Moores director role December 03, 2021Vol.47 No.44
